Chronic kidney disease in diabetes – the forgotten unmet need

shutterstock_2216544289 - image fore home page

Improve diagnosis of kidney disease in T2DM and optimise therapy to reduce residual cardiorenal risk; SGLT-2 inhibition and non-steroidal MRA offer protection against renal disease progression and benefit cardiovascular outcomes

Learning objectives

You will learn:

  • The significant impact of diabetes and kidney disease on individual and global health
  • An approach to the diagnosis and classification of diabetic kidney disease (DKD)
  • The evidence supporting current therapeutic approaches to the management of diabetes and DKD
  • Current evidence regarding residual risk and the importance of aldosterone in the development of chronic kidney disease and cardiovascular disease
  • Current evidence regarding finerenone therapy in patients with DKD.

To access this module, please register or login: